US Biosimilar Impact Set To Overtake Small-Molecule Generics

Biosimilars Set To Reduce Biologic Spending By Over $40bn Through 2026

 
• By Chloe Kent
  
Hand holding a disintegrating one dollar bill
Loss of exclusivity is set to equal loss of profit for branded drug manufacturers. • Source: Shutterstock

More from Biosimilars

More from Products